The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Effect of various concentrations of antibiotics on osteogenic cell viability and activity
Abstract
Infection is a common complication of open fractures. Systemic antibiotics often cause adverse events before eradication of infected bone occurs. The local delivery of antibiotics and the use of implants that deliver both growth factors and antimicrobials are ways to circumvent systemic toxicity while decreasing infection and to reach extremely high levels required to treat bacterial biofilms. When choosing an antibiotic for a local delivery system, one should consider the effect that the antibiotic has on cell viability and osteogenic activity. To address this concern, osteoblasts were treated with 21 different antibiotics over 8 concentrations from 0 to 5,000 µg/ml. Osteoblast deoxyribonucleic acid content and alkaline phosphatase activity (ALP) were measured to determine cell number and osteogenic activity, respectively. Antibiotics that caused the greatest decrement include rifampin, minocycline, doxycycline, nafcillin, penicillin, ciprofloxacin, colistin methanesulfonate, and gentamicin; their cell number and ALP were significantly less than control at drug concentrations ≤200 µg/ml. Conversely, amikacin, tobramycin, and vancomycin were the least cytotoxic and did not appreciably affect cell number and ALP until very high concentrations were used. This comprehensive evaluation of numerous antibiotics' effects on osteoblast viability and activity will enable clinicians and researchers to choose the optimal antibiotic for treatment of infection and maintenance of healthy host bone. © 2011 Orthopaedic Research Society Published by Wiley Periodicals, Inc. J Orthop Res 29: 1070–1074, 2011
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Costerton, J. W., Lewandowski, Z., Caldwell, D. E., Korber, D. R., & Lappin-Scott, H. M. (1995) · Annual Review of Microbiology · doi:10.1146/annurev.mi.49.100195.003431 · Cited by 4,544
Complications Following Limb-Threatening Lower Extremity Trauma
Harris, A. M., Althausen, P. L., Kellam, J., Bosse, M. J., & Castillo, R. (2009) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0b013e31818e43dd · Cited by 341
Whelton, A. (1984) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198411000-00010 · Cited by 320
Microbial Biofilms: Their Development and Significance for Medical Device—Related Infections
Habash, M., & Reid, G. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922008506 · Cited by 287
Infectious Complications of Open Type III Tibial Fractures among Combat Casualties
Johnson, E. N., Burns, T. C., Hayda, R. A., Hospenthal, D. R., & Murray, C. K. (2007) · Clinical Infectious Diseases · doi:10.1086/520029 · Cited by 276
Self-citationDuewelhenke, N., Krut, O., & Eysel, P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00729-05 · Cited by 215
Li, B., Brown, K. V., Wenke, J. C., & Guelcher, S. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.002 · Cited by 198
Self-citationCiprofloxacin Inhibition of Experimental Fracture-Healing*
HUDDLESTON, P. M., STECKELBERG, J. M., HANSSEN, A. D., ROUSE, M. S., BOLANDER, M. E., & PATEL, R. (2000) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200002000-00002 · Cited by 191
Li, B., Yoshii, T., Hafeman, A. E., Nyman, J. S., Wenke, J. C., & Guelcher, S. A. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.038 · Cited by 169
Self-citationGentamicin May Have an Adverse Effect on Osteogenesis
Isefuku, S., Joyner, C. J., & Simpson, A. H. R. W. (2003) · Journal of Orthopaedic Trauma · doi:10.1097/00005131-200303000-00010 · Cited by 163
Cited by
Masters, E. A., Trombetta, R. P., de Mesy Bentley, K. L., Boyce, B. F., Gill, A. L., Gill, S. R., Nishitani, K., Ishikawa, M., Morita, Y., Ito, H., et al. (2019) · Bone Research · doi:10.1038/s41413-019-0061-z · Cited by 575
Versatile Antibacterial Materials: An Emerging Arsenal for Combatting Bacterial Pathogens
Ding, X., Duan, S., Ding, X., Liu, R., & Xu, F. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201802140 · Cited by 489
Cell-based tissue engineering strategies used in the clinical repair of articular cartilage
Huang, B. J., Hu, J. C., & Athanasiou, K. A. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.018 · Cited by 393
Tan, H., Ma, R., Lin, C., Liu, Z., & Tang, T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011854 · Cited by 373
Kazemzadeh-Narbat, M., Lai, B. F. L., Ding, C., Kizhakkedathu, J. N., Hancock, R. E. W., & Wang, R. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.036 · Cited by 361
Biomaterials approaches to treating implant-associated osteomyelitis
Inzana, J. A., Schwarz, E. M., Kates, S. L., & Awad, H. A. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.012 · Cited by 333
Dopamine Modified Organic–Inorganic Hybrid Coating for Antimicrobial and Osteogenesis
Li, M., Liu, X., Xu, Z., Yeung, K. W. K., & Wu, S. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b09457 · Cited by 154
Tan, H., Guo, S., Yang, S., Xu, X., & Tang, T. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.03.013 · Cited by 98
Metadata
- Authors
- Rathbone, C. R., Cross, J. D., Brown, K. V., Murray, C. K., & Wenke, J. C.
- Venue
- Journal of Orthopaedic Research
- Publisher
- Wiley
- Published
- 2011-02-24
- Volume
- 29
- Issue
- 7
- Pages
- 1070-1074
- ISSN
- 0736-0266 (ISSN-L)
- 1554-527X
- OpenAlex
- W1992838633
- Cited by
- 344
- References
- 24
- FWCI
- 13.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.